Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Point72 Asset Management, L.P.'s stake in Cytomx Therapeutics, Inc. fell to 3.60% (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 14, 2026
Point72 Asset Management, L.P.'s stake in Cytomx Therapeutics, Inc. fell to 3.60%, 7,811,033 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G/A).
- Stake
- 3.60%
- Shares
- 7,811,033
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 3.60% | 7,811,033 |
| Point72 Capital Advisors, Inc. | 3.60% | 7,811,033 |
| Steven A. Cohen | 3.60% | 7,811,033 |
Source
Related
- Cytomx Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Cytomx Therapeutics, Inc. shareholders
- Schedule 13G · Point72 Asset Management, L.P. · Apr 16, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Nov 14, 2025
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2025
- Schedule 13G · Point72 Asset Management, L.P. · May 14, 2025
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026
- Schedule 13G · Bank of America Corp · Aug 3, 2026